首页> 外文期刊>World journal of gastroenterology : >Effects and mechanisms of store-operated calcium channel blockade on hepatic ischemia-reperfusion injury in rats.
【24h】

Effects and mechanisms of store-operated calcium channel blockade on hepatic ischemia-reperfusion injury in rats.

机译:钙离子通道阻断对大鼠肝脏缺血再灌注损伤的影响及其机制。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To further investigate the important role of store-operated calcium channels (SOCs) in rat hepatocytes and to explore the effects of SOC blockers on hepatic ischemia-reperfusion injury (HIRI). METHODS: Using freshly isolated hepatocytes from a rat model of HIRI (and controls), we measured cytosolic free Ca(2+) concentration (by calcium imaging), net Ca(2+) fluxes (by a non-invasive micro-test technique), the SOC current (I(SOC); by whole-cell patch-clamp recording), and taurocholate secretion [by high-performance liquid chromatography and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays]. RESULTS: Ca(2+) oscillations and net Ca(2+) fluxes mediated by Ca(2+) entry via SOCs were observed in rat hepatocytes. I(SOC) was significantly higher in HIRI groups than in controls (57.0 +/- 7.5 pA vs 31.6 +/- 2.7 pA, P < 0.05) and was inhibited by La(3+). Taurocholate secretion by hepatocytes into culture supernatant was distinctly lower in HIRI hepatocytes than in controls, an effect reversed by SOC blockers. CONCLUSION: SOCs are pivotal in HIRI. SOC blockers protected against HIRI and assisted the recovery of secretory function in hepatocytes. Thus, they are likely to become a novel class of effective drugs for prevention or therapy of HIRI patients in the future.
机译:目的:进一步研究储库操作性钙通道(SOCs)在大鼠肝细胞中的重要作用,并探讨SOC阻滞剂对肝缺血再灌注损伤(HIRI)的影响。方法:使用来自HIRI大鼠模型(和对照)的新鲜分离的肝细胞,我们测量了胞浆中游离Ca(2+)的浓度(通过钙成像),净Ca(2+)通量(通过无创微测试技术) ),SOC电流(I(SOC);通过全细胞膜片钳记录)和牛磺胆酸盐分泌(通过高效液相色谱法和3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四氮唑测定]。结果:在大鼠肝细胞中观察到通过SOCs介导的Ca(2+)进入介导的Ca(2+)振荡和净Ca(2+)通量。 HIRI组中的I(SOC)显着高于对照组(57.0 +/- 7.5 pA对31.6 +/- 2.7 pA,P <0.05),并被La(3+)抑制。 HIRI肝细胞中肝细胞向培养上清液中的牛磺胆酸盐分泌明显低于对照组,这被SOC阻断剂逆转。结论:SOC在HIRI中至关重要。 SOC阻滞剂可防止HIRI,并有助于肝细胞分泌功能的恢复。因此,它们将来有可能成为预防或治疗HIRI患者的新型有效药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号